parthenolide has been researched along with Cancer of Ovary in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Contreras, JI; Karpf, AR; Kizhake, S; Kour, S; Natarajan, A; Rana, S; Robb, CM; Sonawane, YA; Zahid, M | 1 |
| Kim, W; Kim, YJ; Lee, CS; Lee, SA; Myung, SC | 1 |
2 other study(ies) available for parthenolide and Cancer of Ovary
| Article | Year |
|---|---|
Symbiotic prodrugs (SymProDs) dual targeting of NFkappaB and CDK.
Topics: 4-Butyrolactone; Amines; Antineoplastic Agents; Apoptosis; Cell Line, Tumor; Cell Proliferation; Cyclin-Dependent Kinases; Drug Screening Assays, Antitumor; Female; Humans; Molecular Targeted Therapy; NF-kappa B; Ovarian Neoplasms; Piperazines; Piperidines; Prodrugs; Protein Kinase Inhibitors; Pyrazoles; Pyridines; Sesquiterpenes; Signal Transduction; Structure-Activity Relationship | 2020 |
Combined effect of Hsp90 inhibitor geldanamycin and parthenolide via reactive oxygen species-mediated apoptotic process on epithelial ovarian cancer cells.
Topics: Antineoplastic Combined Chemotherapy Protocols; Apoptosis; bcl-2-Associated X Protein; Benzoquinones; Blotting, Western; Carcinoma, Ovarian Epithelial; Caspase 3; Caspase 8; Caspase 9; Cell Line, Tumor; Cell Survival; Cytochromes c; Female; HSP90 Heat-Shock Proteins; Humans; Lactams, Macrocyclic; Mitochondria; Neoplasms, Glandular and Epithelial; Ovarian Neoplasms; Reactive Oxygen Species; Sesquiterpenes; Tumor Suppressor Protein p53 | 2012 |